Factor B is the central protease of the complement system of immune defense. Here, we present the crystal structure of human factor B at 2.3-Å resolution, which reveals how the five-domain proenzyme is kept securely inactive. The canonical activation helix of the Von Willebrand factor A (VWA) domain is displaced by a helix from the preceding domain linker. The two helices conformationally link the scissile-activation peptide and the metal ion-dependent adhesion site required for binding of the ligand C3b. The data suggest that C3b binding displaces the three N-terminal control domains and reshuffles the two central helices.
Factor B is a tightly regulated, highly specific serine protease. In its activated form, it catalyzes the central amplification step of complement activation to initiate inflammatory responses, cell lysis, phagocytosis and B-cell stimulation 1, 2 . Factor B is activated through an assembly process: it binds surface-bound C3b, or its fluid-phase counterpart C3(H 2 O), after which it is cleaved by factor D into fragments Ba (residues 1-234) and Bb (residues 235-739) 3, 4 . Fragment Ba dissociates from the complex, leaving behind the alternative pathway C3 convertase complex C3b-Bb, which cleaves C3 into C3a and C3b (see Fig. 1a ). This protease complex is intrinsically instable. Once dissociated from the complex, Bb cannot reassociate with C3b 5 . A similar C3 convertase complex is formed upon activation of the classical (antibody-mediated) and lectin-binding pathways, comprised of C4 and C2, which are homologous to C3 and factor B, respectively. The proenzyme factor B consists of three N-terminal complement control protein (CCP) domains, connected by a 45-residue linker to a VWA domain and a C-terminal serine protease (SP) domain, which carries the catalytic center (Fig. 1a) . The VWA and SP domains form fragment Bb, and CCP1 through CCP3 and the linker form fragment Ba. Binding of factor B to C3b depends on elements in fragment Ba 6 and the Mg 2+ -dependent metal ion-dependent adhesion site (MIDAS) motif in the VWA domain of fragment Bb 7 . The VWA domain is structurally homologous to inserted (I) domains in integrins. In I domains, ligand binding to the MIDAS is coupled to a B10-Å shift of the a7 activation helix, with concomitant domain rearrangements that activate the integrins 8, 9 . Structures of a truncated Bb fragment 10 and its full-length homolog C2a 11 show variable positions of the a7 activation helix affecting the orientation of the VWA and SP domains, which indicates that a related mechanism may occur in convertase formation and dissociation. These structures, however, do not reveal the regulation of the proteolytic activity of factor B. In particular, it is unclear how factor B is maintained in its inactive, zymogen state and how C3b binding makes factor B susceptible to proteolytic activation by factor D. To gain insights into the regulatory mechanisms underlying complement activation, we set out to determine the structure of human proenzyme factor B.
RESULTS
Overall structure of factor B Here we present the crystal structure of human proenzyme factor B at 2.3-Å resolution (see Methods and Supplementary Fig. 1 online) . The overall structure (Fig. 1b) consists of three lobes, which is in agreement with electron micrographs 12 . One lobe represents the trypsinlike SP domain with the catalytic site in a fully exposed position. The other two lobes represent the VWA domain, with its a/b/a fold, and the CCP1-CCP3 domains, with their typical b-sandwich fold stabilized by pairs of disulphide bonds. The long CCP3-VWA linker, containing the Arg234-Lys235 scissile bond, forms a short loop (residues 198-201), an a-helix (residues 202-213) and a long loop (residues 214-242), which is partially disordered (residues 219-232 are not evident in the electron density). Unexpectedly, the observed linker helix, denoted aL, is integrated into the VWA domain and occupies the position of the a7 activation helix in fragment Bb 10 (Fig. 2a) . The displaced a7 helix lies adjacent to aL on the surface of the VWA domain. These two helices lie at the center of the five-domain molecule and affect the domain-domain arrangement (Fig. 1b) . They provide a conformational link between two key regulatory sites of the molecule: the Mg 2+ -dependent C3b-binding MIDAS on one side and the activation scissile bond Arg234-Lys235 on the opposite side of the molecule.
VWA domain adopts locked conformation
The VWA domain in factor B adopts an inactive conformation with a displaced helix a7 and distorted MIDAS, which we refer to as a 'locked' conformation. The inactive-closed and active-open conformational states of the VWA and I domains are characterized predominantly by the conformations of loop bF-a7, helix a7 and the neighboring helix a1 (Fig. 2b) 8, 13 . In factor B, helix a7 is displaced from its normal binding groove by helix aL (Fig. 2a) . The preceding loop, bF-a7, adopts a canonical closed conformation, as shown by the positions of its hydrophobic ratchet residues (Val430 and Leu436; see Fig. 2b and Supplementary  Fig. 2 online) . Helix a1 is also positioned in the inactive-closed conformation. Thus, the unliganded VWA domain has an inactive conformation, as would be expected for the proenzyme state of factor B. Moreover, helix aL obstructs the a7 activation helix, preventing it from taking its normal position in VWA and I domains 8, 10, 11, [13] [14] [15] , thereby locking the VWA domain in its inactive conformation. Typically, a closed-inactive domain conformation is coupled to a MIDAS conformation with a low affinity for ligands. In factor B, compared with fragment Bb, displacements up to 5.5 Å in loops bAa1 and bD-a5 distort the MIDAS (Fig. 2c and Supplementary Fig. 2 ).
The distorted conformation indicates reduced divalent-ion binding. Moreover, we did not observe electron density for an ion bound to the MIDAS in factor B. The absence of an ion is consistent with the notion that fragment Bb, but not factor B, has high affinity for divalent ions 16 . The neighboring CCP1 domain may affect the MIDAS conformation. Gln28 of loop b2-b3 in CCP1 makes a hydrogen bond to Asp254, located in the displaced VWA bA-a1 loop. Furthermore, CCP1 may prevent loop bA-a1 from assuming the conformation seen in Bb by obstructing the glycan at Asn260. Instead, in factor B helix a1 is shifted and partially unwound, pointing the glycan on Asn260 away from the neighboring CCP1 domain (Fig. 2c) . Factor B with D254G and N260D single and double mutations (where N260D deletes the N-glycosylation site) forms convertases more readily and more stably than wild-type factor B 17, 18 , indicating that these mutations promote the transition from an inactive to an active conformation of the VWA domain.
Central role for linker region
The CCP3-VWA linker helix aL occupies the position of helix a7 of the VWA domain. It binds Arg234 of the scissile bond, preventing proteolytic activation. By virtue of its short-chain hydrophobic residues, helix aL is squeezed between helix a7 and the VWA core, effectively blocking helix a7 (Fig. 2a) . After helix aL, the CCP3-VWA linker forms a long loop and folds back to the C-terminal end of helix aL (Fig. 2d) . The scissile bond Arg234-Lys235 is located here, buried by the preceding flexible loop. The side chain of Arg234, crucial for substrate binding at the S1 pocket (as defined in Schechter and Berger notation) of factor D, is bound to both helix aL (Glu207) and helix a7 (Glu446) by salt bridges (Fig. 2d) . Thus, the scissile bond in factor B is protected from proteolysis by factor D and is conformationally linked to helices aL and a7. In contrast, the scissile bond in isolated VWA domains is susceptible to factor D cleavage 19 , because they lack the aL-a7 arrangement that locks the P1 residue (Arg234). In the formation of the convertase, binding of C3b to factor B probably induces reshuffling of helices aL and a7 that liberates the P1 arginine residue and makes the scissile bond accessible for proteolysis by factor D.
Conformation of the catalytic SP domain
In both factor B and fragment Bb 10 , the SP domain is exposed and the catalytic site is freely accessible to small substrates 20 . The two structures differ markedly in the orientation of the VWA-SP region (Fig. 3a) . In factor B, the VWA-SP interface is dominated by helices aL and a7, with the N-terminal loop of SP folding over helix aL; furthermore, contacts are observed between SP and domains CCP1 and CCP2. In fragment Bb, where aL and the CCP1-CCP3 domains are absent, SP rotates 681 and contacts helices a7, a1 and a3 of the VWA domain. In addition to the interface loops, loop 2 of the SP domain is markedly different in factor B and fragment Bb. Putatively, Arg705 of this loop (like Arg696 in C2a 11 ) induces formation of the oxyanion hole, similar to the N terminus in trypsin after proteolytic activation of trypsinogen 21 . Consistent with this model, the guanidinium group of the arginine interacts with an aspartate of the oxyanion-hole loop in Bb and C2a ( Supplementary Fig. 3 online) . In factor B, loop 2 folds back toward the N-glycosylated Asn97 on CCP2 (weak electron density for the side chains indicates disorder in loop 2). Concomitantly, the guanidinium group of Arg705 is displaced by 11 Å , as would be expected for the zymogen state. Nevertheless, the conformation of the oxyanion hole is identical between factor B and fragment Bb-that is, in factor B, the oxyanion-hole loop does not adopt the zymogen state. This indicates that proteolytic activity of factor B is probably not controlled directly, as in trypsinogens, but rather through quaternary rearrangement of the domains in the assembly process.
Triad of CCP domains
The three CCP domains of fragment Ba adopt an unexpected triad arrangement, with domains CCP2 and CCP3 packed tightly (Supplementary Table 1 online) into an antiparallel dimer capped by CCP1. This arrangement produces a small hydrophobic core at the triad center (Fig. 3b) . Changes in the CCP2-CCP3 interface reduce C3b binding and hemolytic activity 22, 23 , and antibodies directed against CCP1 and CCP3 block hemolytic activity 22, 24 ( Supplementary Fig. 4 online), indicating that the triad of CCP domains provides an important binding site for C3b. Domain CCP1 probably hinders access of the ligand C3b to the Mg 2+ -dependent MIDAS of the VWA domain ( Supplementary Fig. 5 online) . Because the triad of CCP domains appears to be only weakly associated with the VWA and SP domains ( Supplementary Fig. 4 and Supplementary Table 2 online), we hypothesize that binding of the CCP domains to C3b dislocates the CCP triad from the VWA and SP domains. Concomitantly, dislocation of the CCP triad may be coupled, through the short CCP3-aL connecting loop (Fig. 3b) , to displacement of helix aL from its binding groove in the VWA domain. factor B locked in its proenzyme state. The structure adds this locked conformation to the open and closed conformations described in past studies of the VWA and I domains 8, 9 and provides insights into a previously uncharacterized mechanism for regulating serine protease activity 21 . Assembly of an active protease complex probably proceeds through a number of steps. We hypothesize that initial binding of C3b dislocates the CCP triad. In turn, dislocation of the CCPs probably induces formation of an active MIDAS and allows access of the large C3b ligand. Concomitantly, the blocking helix aL is displaced from its position in the VWA domain, thereby allowing the activation helix a7 to move into its normal location. Rearrangement of helices aL and a7 liberates the bound scissile peptide, making it accessible for proteolytic cleavage by factor D. Cleavage of the scissile bond results in dissociation of the Ba fragment, yielding the active, short-lived protease complex that cleaves C3 into C3a and C3b. Thus, the tight regulation of complement activation is determined by a series of conformational changes that establish the C3 convertase activity required for amplification, which is crucial for the biological functions of the complement system.
DISCUSSION

METHODS
Protein expression, purification and crystallization. Human factor B fused to an N-terminal Gly-Ser-(His) 6 -Gly-Ser tag was expressed in human embryonic kidney 293S GnTI -cells to prevent complex and heterogeneous N-linked glycosylation 25 . Secreted factor B was purified from the expression medium via immobilized metal affinity chromatography followed by size-exclusion chromatography. The purified protein showed a single band of 90 kDa on Coomassie-stained SDS-PAGE gels and on western blots probed with an antibody to His 6 . Details of factor B expression and purification are given in Supplementary Methods online. Crystals were grown by hanging drop vapor diffusion by mixing 1 ml factor B (13 mg ml -1 ) in 10 mM tris(hydroxymethyl) Table 1 .
Structure determination. The SP and VWA domain were placed by molecular replacement using Phaser 27 with structures of the isolated SP (PDB 1DLE) 28 and VWA (PDB 1Q0P) 14 domains of factor B as search models. Subsequent placement of the three CCP domains using various homologous structures, as well as model completion by automated model building using ARP/wARP 29 , failed at this stage. The VWA helix a7 and SP domain loops C and D were rebuilt and the partial model was refined using COOT 30 , RESOLVE 31 and REFMAC5 (ref. 32) . Using this partial model, ARP/wARP then successfully completed the model to B80%.
Iterative cycles of refinement with REFMAC5 and model building in COOT were used to finalize the model. The refined model of factor B contains 710 residues; residues 1-8, 218-232, 321-326 and 344-346 were excluded from the model because of poor electron density. R and R free values were 19.5% and 24.1%, respectively (see Table 1 for refinement statistics). All molecular graphic figures were generated with PyMOL (http:// pymol.sourceforge.net).
Accession codes. Protein Data Bank: Coordinates and structure factors have been deposited with accession code 2OK5.
Note: Supplementary information is available on the Nature Structural & Molecular Biology website. Values in parentheses are for highest-resolution shell.
